Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis

Abstract

Sleep disturbance is common and persistent in women with ovarian cancer, and is linked to depressive symptoms and QOL. Pharmacologic treatment does not appear to adequately address this problem. Results highlight the need for ongoing screening and intervention for sleep disturbance in this population.